{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:22:24Z","timestamp":1793467344207,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.hfc.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T21:17:48Z","timestamp":1712783868000},"page":"317-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Genotype-Phenotype Correlations in ATTR Amyloidosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Emanuele","family":"Monda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Verrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palmiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Aimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.hfc.2024.03.006_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.hfc.2024.03.006_bib2","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.03.006_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13023-022-02359-w","article-title":"Clinical and genetic profile of patients enrolled in the transthyretin amyloidosis outcomes survey (THAOS): 14-year update","volume":"17","author":"Dispenzieri","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.hfc.2024.03.006_bib4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archneur.62.7.1057","article-title":"Transthyretin-related familial amyloidotic polyneuropathy","volume":"62","author":"Ando","year":"2005","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2024.03.006_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","article-title":"Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP","volume":"29","author":"Parman","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.hfc.2024.03.006_bib6","article-title":"Transthyretin amyloidosis in Western Europe: a snapshot from the THAOS registry and a call for further perspectives","author":"Ammirati","year":"2019","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.hfc.2024.03.006_bib7","doi-asserted-by":"crossref","first-page":"e010687","DOI":"10.1161\/CIRCHEARTFAILURE.123.010687","article-title":"Targeted therapies in pediatric and adult patients with hypertrophic heart disease: from molecular pathophysiology to personalized medicine","volume":"16","author":"Monda","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hfc.2024.03.006_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2022.03.050","article-title":"Diagnosis and management of rare cardiomyopathies in adult and paediatric patients. a position paper of the italian society of cardiology (sic) and italian society of paediatric cardiology (SICP)","volume":"357","author":"Limongelli","year":"2022","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2024.03.006_bib9","first-page":"2109","article-title":"Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy","volume":"268","author":"Adams","year":"2021","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.hfc.2024.03.006_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.24725","article-title":"Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?","volume":"80","author":"Loavenbruck","year":"2016","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.hfc.2024.03.006_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00401-022-02501-9","article-title":"Neuropathology of central nervous system involvement in TTR amyloidosis","volume":"145","author":"Taipa","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2024.03.006_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10286-019-00628-6","article-title":"Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis","volume":"29","author":"Obici","year":"2019","journal-title":"Clin Auton Res"},{"issue":"2","key":"10.1016\/j.hfc.2024.03.006_bib13","first-page":"528","article-title":"Pathophysiology, functional assessment and prognostic implications of nutritional disorders in systemic amyloidosis","volume":"12","author":"Dongiglio","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"11","key":"10.1016\/j.hfc.2024.03.006_bib14","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1136\/jmg.40.11.e120","article-title":"Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families","volume":"40","author":"Plant\u00e9-Bordeneuve","year":"2003","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.hfc.2024.03.006_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40942-021-00357-x","article-title":"Conjunctival lymphangiectasia and retinal angiopathy in hereditary transthyretin amyloidosis","volume":"8","author":"Patil","year":"2022","journal-title":"Int J Retina Vitreous"},{"issue":"6","key":"10.1016\/j.hfc.2024.03.006_bib16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.24519","article-title":"Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France","volume":"78","author":"Mariani","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.hfc.2024.03.006_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13023-022-02481-9","article-title":"Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China","volume":"17","author":"He","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"19","key":"10.1016\/j.hfc.2024.03.006_bib18","doi-asserted-by":"crossref","first-page":"e2036","DOI":"10.1212\/WNL.0000000000207158","article-title":"Phenotypes associated With the Val122Ile, Leu58His, and late-onset Val30Met variants in patients with hereditary transthyretin amyloidosis","volume":"100","author":"Zampino","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.hfc.2024.03.006_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: the great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hfc.2024.03.006_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2021.07.035","article-title":"External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis","volume":"339","author":"Monda","year":"2021","journal-title":"Int J Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2024.03.006_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10286-019-00629-5","article-title":"Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis","volume":"29","author":"Puig-Carrion","year":"2019","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1016\/j.hfc.2024.03.006_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.hfc.2021.07.014","article-title":"The role of new imaging technologies in the diagnosis of cardiac amyloidosis","volume":"18","author":"Palmiero","year":"2022","journal-title":"Heart Fail Clin"},{"issue":"3","key":"10.1016\/j.hfc.2024.03.006_bib23","first-page":"868","article-title":"Multimodality imaging in cardiomyopathies with hypertrophic phenotypes","volume":"11","author":"Monda","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.hfc.2024.03.006_bib24","doi-asserted-by":"crossref","first-page":"131147","DOI":"10.1016\/j.ijcard.2023.131147","article-title":"Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis","volume":"388","author":"Palmiero","year":"2023","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2024.03.006_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.hfc.2021.07.006","article-title":"Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.hfc.2024.03.006_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2019.06.073","article-title":"Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy","volume":"299","author":"Limongelli","year":"2020","journal-title":"Int J Cardiol"},{"issue":"22","key":"10.1016\/j.hfc.2024.03.006_bib27","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2024.03.006_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/ahe.13.10","article-title":"Comparison of cardiac amyloidosis due to wild-type and V122I transthyretin in older adults referred to an academic medical center","volume":"9","author":"Givens","year":"2013","journal-title":"Aging Health"},{"issue":"9","key":"10.1016\/j.hfc.2024.03.006_bib29","doi-asserted-by":"crossref","first-page":"e003352","DOI":"10.1161\/CIRCHEARTFAILURE.116.003352","article-title":"Afro-caribbean heart failure in the United Kingdom: cause, outcomes, and ATTR V122I cardiac amyloidosis","volume":"9","author":"Dungu","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"9","key":"10.1016\/j.hfc.2024.03.006_bib30","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/eurheartj\/ehr383","article-title":"Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant","volume":"33","author":"Sattianayagam","year":"2012","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.hfc.2024.03.006_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/eurheartj\/ehz173","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"43","author":"Damy","year":"2019","journal-title":"Eur Heart J"},{"issue":"s2","key":"10.1016\/j.hfc.2024.03.006_bib32","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.3233\/JND-150091","article-title":"Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in sicily, an italian endemic area","volume":"2","author":"Mazzeo","year":"2015","journal-title":"JND"},{"issue":"4","key":"10.1016\/j.hfc.2024.03.006_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13506129.2019.1634539","article-title":"Founder effect of the Glu89Gln TTR mutation in the Bulgarian population","volume":"26","author":"Kirov","year":"2019","journal-title":"Amyloid"},{"issue":"10","key":"10.1016\/j.hfc.2024.03.006_bib34","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ejhf.1285","article-title":"Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure","volume":"20","author":"Gagliardi","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.hfc.2024.03.006_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40119-021-00226-6","article-title":"Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS","volume":"10","author":"Gentile","year":"2021","journal-title":"Cardiol Ther"},{"issue":"6","key":"10.1016\/j.hfc.2024.03.006_bib36","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"16","key":"10.1016\/j.hfc.2024.03.006_bib37","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:26:24Z","timestamp":1717590384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1551713624000242"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.03.006","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotype-Phenotype Correlations in ATTR Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}